Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
185M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
4.41M
-
Shares change
-
+4.4M
-
Total reported value, excl. options
-
$44.7M
-
Value change
-
+$44.6M
-
Number of buys
-
20
-
Price
-
$10.16
Significant Holders of HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) as of Q4 2020
21 filings reported holding AHAC - HUMACYTE, INC. - Common Stock, par value $0.0001 per share as of Q4 2020.
HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.41M shares
of 185M outstanding shares and own 2.39% of the company stock.
Largest 10 shareholders include OMNI PARTNERS LLP (1.08M shares), BOOTHBAY FUND MANAGEMENT, LLC (610K shares), Tudor Investment Corp Et Al (543K shares), Periscope Capital Inc. (450K shares), CNH PARTNERS LLC (300K shares), BERKLEY W R CORP (231K shares), MANGROVE PARTNERS (214K shares), Charles Winkler (200K shares), Weiss Asset Management LP (200K shares), and Alberta Investment Management Corp (140K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.